C12N 2770/24063
By chemical treatment
Official title: by chemical treatment
C12N2770/24063 (By chemical treatment) appears on 5 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 6
- Assignees
- 7
- Inventors
- 21
- Latest grant
- 11 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 2 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Compounds and methods for diagnosis and treatment of viral infections11 Jun 2024US 12,005,122 B2Navidea Biopharmaceuticals, Inc.
- Zika virus vaccine and methods of production15 Jun 2021US 11,033,615 B2The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland
- Compounds and methods for diagnosis and treatment of viral infections18 May 2021US 11,007,272 B1Navidea Biopharmaceuticals, Inc.
- Modified viral particles with immunogenic properties and reduced lipid content5 Aug 2008US 7,407,662 B2Lipid Sciences, Inc.
- Method of attenuating viruses with simultaneous stabilization of their antigens using selected aminomethylol compounds21 Sep 1976US 3,981,772 A
- Compounds and methods for diagnosis and treatment of viral infections4 Nov 2021US 2021/0338827 A1Navidea Biopharmaceuticals, Inc.
- Zika virus vaccine and methods of production11 Jun 2020US 2020/0179506 A1Government of the United States of America, AS Represented By the Secretary of the Army
- Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases20 Feb 2014US 2014/0050763 A1Eli Lilly and Company
- Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases29 Jan 2009US 2009/0028902 A1Lipid Sciences, Inc.
- Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases30 Oct 2008US 2008/0267997 A1Lipid Sciences, Inc.
Most cited
By later US patents
- Method of attenuating viruses with simultaneous stabilization of their antigens using selected aminomethylol compounds6US 3,981,772 A1976
- Modified viral particles with immunogenic properties and reduced lipid content4US 7,407,662 B2Lipid Sciences, Inc. · 2008
- Compounds and methods for diagnosis and treatment of viral infections3US 11,007,272 B1Navidea Biopharmaceuticals, Inc. · 2021